{"id":"NCT05600322","sponsor":"Photocure","briefTitle":"Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer","officialTitle":"A Prospective, Comparative Within Patient Controlled, Multi-center Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-11-03","primaryCompletion":"2023-07-12","completion":"2023-07-12","firstPosted":"2022-10-31","resultsPosted":"2024-10-03","lastUpdate":"2024-10-03"},"enrollment":158,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Bladder Cancer"],"interventions":[{"type":"DRUG","name":"Hexaminolevulinate Hydrochloride","otherNames":["Hexvix"]},{"type":"DEVICE","name":"Richard Wolf Photodynamic Diagnostic Equipment (PDD) system","otherNames":["System Blue"]}],"arms":[{"label":"Hexvix Blue light cystoscopy","type":"EXPERIMENTAL"}],"summary":"A study to compare Hexvix Blue light cstoscopy with standard White light cystoscopy in the detection of bladder cancer.","primaryOutcome":{"measure":"Number of Patients With Histology-confirmed Lesions (Ta, T1, or CIS) Who Have at Least One Such Lesion Found by Hexvix Blue Light Cystoscopy But Not by White Light Cystoscopy.","timeFrame":"1 day (At time of cystoscopy examination)","effectByArm":[{"arm":"Hexvix Blue Light Cystoscopy","deltaMin":42,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":7,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":158},"commonTop":["Hypoalbuminaemia","Incision site pain","Blood bilirubin increased","Urinary tract infection","Anaemia"]}}